TP53 and colorectal carcinoma: Of note, relapse after chemotherapy remains the obstacle to improving clinical outcomes of CRC patients, a critical mechanism is that 5-Fluorouracil elevates CRC stemness by activating TP53-mediated WNT signaling pathway (13).